Condition (MeSH)
Renal Artery Obstruction
ClinicalTrials.gov lists 51 trials for Renal Artery Obstruction or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
51 of the 51 trials are tagged with Renal Artery Obstruction itself; the rest are tagged with a narrower condition beneath it.
When did Renal Artery Obstruction trials start? (27)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 5
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 1 |
| 2023 | 3 |
| 2022 | 1 |
| 2021 | 1 |
| 2020 | 1 |
| 2019 | 1 |
| 2018 | 3 |
| 2017 | 1 |
| 2016 | 2 |
Showing 10 of 27 earlier years.
No forecast is made for this condition: it averages 1.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Renal Artery Obstruction trials in? (8)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 4 |
| Phase 1/2 | 1 |
| Phase 2 | 4 |
| Phase 2/3 | 2 |
| Phase 3 | 10 |
| Phase 4 | 4 |
| Not applicable | 11 |
| Observational | 15 |
How many Renal Artery Obstruction trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Recruiting | 2 |
| Completed | 29 |
| Terminated | 3 |
| Withdrawn | 1 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Renal Artery Obstruction trials? (6)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Abbott Medical Devices | 2 |
| Bayer | 2 |
| Cook Group Incorporated | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Atrium Medical Corporation | 1 |
Showing 5 of 6 sponsors.
Interventions as named in the registry (15)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Gadobutrol~0.03 mmol/kg BW (Gadavist, Gadovist, BAY86-4875) | 1 |
| 15O-water | 1 |
| Mesenchymal Stem Cell | 1 |
| domestic polysaccharide superparamagnetic iron oxide nanoparticle | 1 |
| NaCl preconditioning before renal artery stenosis dilation | 1 |
Showing 5 of 15 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Renal Artery Obstruction trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Cardiac Disorders | 245 | 1 |
| Infections and Infestations | 132 | 1 |
| Nervous System Disorders | 128 | 1 |
| Gastrointestinal Disorders | 99 | 1 |
| General Disorders | 74 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Renal Artery Obstruction? (108)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Quality of life effects of renal artery stenting versus medical therapy for atherosclerotic renal-artery stenosis: results from the randomized CORAL trial. | European heart journal. Quality of care & clinical outcomes | 2025 | Yes |
| Retrospective analysis of percutaneous intervention of the renal artery in transplanted kidneys in children and adolescents at a tertiary public hospital. | PloS one | 2024 | Yes |
| Efficacy and safety of low-dose aspirin on preventing transplant renal artery stenosis: a prospective randomized controlled trial. | Chinese medical journal | 2023 | Yes |
| Drug-coated balloon for treatment of non-atherosclerotic renal artery stenosis-a multi-center study. | BMC cardiovascular disorders | 2023 | Yes |
| Renal Artery Stenting in Consecutive High-Risk Patients With Atherosclerotic Renovascular Disease: A Prospective 2-Center Cohort Study. | Journal of the American Heart Association | 2022 | Yes |
Showing 5 of 108 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.